secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2026-04-06T23:59:59+00:00
Accession:  0001193125-26-143703
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen appoints Vafa Jamali to board, enters cooperation agreement with Kent Lake
--------------------------------------------------------------------------------

- Vafa Jamali appointed as independent Class I director effective June 15, 2026 or 2026 annual meeting.
- Jamali previously CEO of ZimVie and SVP/President of Medtronic's $3B Respiratory, GI & Informatics division.
- Cooperation agreement with Kent Lake includes standstill, voting commitment, and 4.99% ownership cap.
- Jamali to receive $180k initial RSU grant, plus annual cash fees of $60k for board and committee roles.
- Kent Lake agreed to vote shares per board recommendations except on extraordinary transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000119312526143703/0001193125-26-143703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000119312526143703/ingn-20260406.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-143703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer